With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
Share
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
How Tech Can Bridge Gaps in Rural Healthcare Data Struggles
Prescription price transparency and nationwide data sharing are among the areas in which officials say technology can reduce costs.
4m read -
Army Launches Joint Innovation Outpost to Accelerate Battlefield Capabilities
At Fort Bragg, the XVIII Airborne Corps’ Joint Innovation Outpost connects soldiers, engineers and industry to accelerate battlefield capability development.
23m listen -
Navigating Federal Cloud Adoption
HHS leaders share how hybrid cloud strategies are evolving, integrating zero trust and shaping future cloud capabilities.
19m watch Partner Content -
CMS Orders Medicaid Audits in Data-Driven Fraud Crackdown
The agency told states to submit plans within 30 days to verify providers and root out waste, fraud and abuse.
2m read
